Asia-Pacific Cardiovascular Disease Alliance
The APAC CVD Alliance's mission is to improve heart health for everyone in the Asia-Pacific.
The Cardiovascular Disease Alliance strives to be a leading voice and trusted authority on cardiovascular disease in the Asia-Pacific. We aim to build up Asia Pacific heart health with patients at the center by uniting action around shaping policy, building awareness, and implementing programmes with evidence-based research. ACCESS Health Southeast Asia serves as the Secretariat for the CVD Alliance.
12/08/2023
Four principles guide all of our work at the APAC CVD Alliance:
1️⃣ Advance health equity
2️⃣ Adopt a patient-centered approach
3️⃣ Apply evidence-based research
4️⃣ Build interdisciplinary, multisectoral partnerships
Read more about our Alliance charter: https://apac-cvd.org/our-charter/
Our Charter - APAC CVD Alliance APAC CVD Alliance Charter Our Charter highlights the Alliance’s policy statements to drive united heart health action in the Asia-Pacific. 01. Background The Asia-Pacific is a dynamic and fast-growing region with socio-economic, ethnic, and cultural diversity with more than 4 billion people and 60...
25/07/2023
Meet our Alliance advisor Farhad Ali from Vital Strategies! As a public health development professional in Asia, Farhad shares more about his work in promoting health in all sectors.
Learn more about Farhad and the APAC CVD Alliance on our website: https://apac-cvd.org
13/07/2023
Meet our Alliance strategic partner!
Dr Tony Badrick is President of the Asia Pacific Federation for Clinical Biochemistry and Laboratory Medicine and CEO of The Royal College of Pathologists of Australasia RCPA Quality Assurance Programs since 2015.
Tony shares with us his passion to integrate data, mathematics and laboratories to create better health systems.
Dr Tony Badrick: Connecting data, mathematics and laboratories for better health systems - APAC CVD Alliance As CEO of the Royal College of Pathologists Australasia Quality Assurance Programs (RCPAQAP) since 2015, Dr Tony Badrick is not just an accomplished clinical biochemist...
07/07/2023
Heart disease is growing in Asia, with rapid urbanization, aging populations, and poor health outcomes. Our new Asia-Pacific Cardiovascular Disease Alliance (APAC CVD Alliance) aims to increase public and policy awareness of CVD, encourage innovation, and emphasize a holistic approach to improve heart health for patients, societies, and economies.
Visit us: https://apac-cvd.org
27/06/2023
We are pleased to announce the launch of the Asia-Pacific Cardiovascular Disease Alliance (APAC CVD Alliance), a multisectoral, multistakeholder coalition committed to tackling heart disease and stroke which is the leading killer in Asia.
Our mission is to improve heart health and reduce the CVD burden for patients, societies, and economies in the Asia-Pacific. We will do this by raising public and policy awareness of CVD at regional and domestic forums in Asia. We look to partner with patients, healthcare professionals, payers, academia, industry, non-profits and policymakers across the entire CVD care continuum to encourage the implementation of sustainable, scalable CVD innovations in Asia.
Thanks to our strategic partners, Asia Pacific Federation for Clinical Biochemistry and Laboratory Medicine, Global Alliance for Patient Access, Global Heart Hub, UNIVERSITI TEKNOLOGI MARA (UiTM) Faculty of Medicine in Malaysia, and corporate partners Amgen, Novartis and Roche Diagnostics. Access Health International is the secretariat based in Singapore.
We are rapidly expanding our network in the region - drop us a message if you'd like to collaborate with us! Read more at our website:
New coalition formed to fight heart disease across Asia - APAC CVD Alliance Today, patient organizations, allied health professionals, academia, corporate partners and a global health think-tank came together to launch the Asia-Pacific Cardiovascular Disease Alliance (APAC CVD Alliance)
Globally, cardiovascular disease rank as the highest causes of death and health loss. It is imperative for health systems to prioritise strengthening preventive and CVD care to address the growing mortality of CVD which killed more than 10 million people in Asia in 2019 alone.
Read more in the Journal of American College of Cardiology